MENLO PARK, Calif. and CINCINNATI, Dec. 3, 2025 /PRNewswire/ -- MyOme, a leading clinical whole-genome testing and polygenic risk modelling (PRS) company, today announced a strategic partnership with ...
MENLO PARK, Calif., Jan. 30, 2025 /PRNewswire/ -- MyOme, a leading clinical innovation whole genomic analysis and polygenic risk modelling (PRS) company announced a strategic partnership with Novi ...
In a major step toward expanding patient access, MyOme is highlighting its strategic partnership with Natera (NASDAQ: NTRA) to launch Zenith™ powered by MyOme. Zenith is a premium exome and genome ...
MyOme, Inc., a leader in clinical whole-genome analysis and polygenic risk modeling, today announced that its predictive genomic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results